Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|November 8, 2002
Epidermal growth factor receptor expression and measurement in solid tumorsDavid C Spaulding, Betsy O Spaulding
Human Pathology|December 17, 2009
IMP3 expression is correlated with histologic grade of lung adenocarcinomaJennifer J Findeis-Hosey, Qi Yang, Betsy O Spaulding, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 22, 2008
IMP-3 is a novel progression marker in malignant melanomaJennifer G Pryor, Patricia A Bourne, Qi Yang, et al.
Cancer|December 22, 2007
Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusionsKrisztina Z Hanley, Michael S Facik, Patricia A Bourne, et al.
Human Pathology|June 13, 2008
Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumorsLin Li, Haodong Xu, Betsy O Spaulding, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 13, 2012
IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liverKristopher S Denby, Alice J Briones, Patricual A Bourne, et al.
Pageof 2